399 related articles for article (PubMed ID: 18177833)
1. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
2. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
3. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
4. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
5. The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
Jindabanjerd K; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S147-51. PubMed ID: 17726816
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Bragheto AM; Caserta N; Bahamondes L; Petta CA
Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
[TBL] [Abstract][Full Text] [Related]
7. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
8. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
He SM; Zhang YD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
[TBL] [Abstract][Full Text] [Related]
11. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
12. Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis.
Lee KH; Kim JK; Lee MA; Ko YB; Yang JB; Kang BH; Yoo HJ
Arch Gynecol Obstet; 2016 Sep; 294(3):561-6. PubMed ID: 27155971
[TBL] [Abstract][Full Text] [Related]
13. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
[TBL] [Abstract][Full Text] [Related]
14. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid as a therapy for adenomyosis: a comparative case series.
Xishi Liu ; Lei Yuan ; Guo SW
Reprod Sci; 2010 Oct; 17(10):904-12. PubMed ID: 20601534
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
[TBL] [Abstract][Full Text] [Related]
17. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O
Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358
[TBL] [Abstract][Full Text] [Related]
18. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
Lockhat FB; Emembolu JO; Konje JC
Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Song SY; Lee SY; Kim HY; Park DB; Kim DE; Lee KH; Lee S; Yang JB; Yoo HJ
Medicine (Baltimore); 2020 May; 99(22):e20421. PubMed ID: 32481439
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
